These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24412350)

  • 1. Vaccines at what price?
    Stephens DS; Ahmed R; Orenstein WA
    Vaccine; 2014 Feb; 32(9):1029-30. PubMed ID: 24412350
    [No Abstract]   [Full Text] [Related]  

  • 2. [National economic consequences of vaccines].
    Bergman A; Persson U
    Lakartidningen; 2008 May 28-Jun 3; 105(22):1680-4. PubMed ID: 18590011
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vaccination--value for money?].
    Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Kristiansen IS
    Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2670-3. PubMed ID: 17057767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiered pricing of vaccines: a win-win-win situation, not a subsidy.
    Plahte J
    Lancet Infect Dis; 2005 Jan; 5(1):58-63. PubMed ID: 15620562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Economic evaluation of an infant immunization program in Mexico, based on 13-valent pneumococcal conjugated vaccines].
    Muciño-Ortega E; Mould-Quevedo JF; Farkouh R; Strutton D
    Value Health; 2011; 14(5 Suppl 1):S65-70. PubMed ID: 21839902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.
    Chotivitayatarakorn P; Chotivitayatarakorn P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):114-25. PubMed ID: 20578490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An economic evaluation of thermostable vaccines in Cambodia, Ghana and Bangladesh.
    Levin A; Levin C; Kristensen D; Matthias D
    Vaccine; 2007 Sep; 25(39-40):6945-57. PubMed ID: 17707556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological issues and new developments in the economic evaluation of vaccines.
    Beutels P; Van Doorslaer E; Van Damme P; Hall J
    Expert Rev Vaccines; 2003 Oct; 2(5):649-60. PubMed ID: 14711326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of potential medical and economic benefits of universal rotavirus vaccination in Greece.
    Syriopoulou V; Kafetzis D; Theodoridou M; Syrogiannopoulos GA; Mantagos S; Trimis G; Mavrikou M; Konstantopoulos A
    Acta Paediatr; 2011 May; 100(5):732-9. PubMed ID: 21223372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of a 3-dose pneumococcal conjugate vaccine program in the province of Quebec, Canada.
    Poirier B; De Wals P; Petit G; Erickson LJ; Pépin J
    Vaccine; 2009 Nov; 27(50):7105-9. PubMed ID: 19786137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of a routine rotavirus vaccination programme in Indonesia.
    Wilopo SA; Kilgore P; Kosen S; Soenarto Y; Aminah S; Cahyono A; Ulfa M; Tholib A
    Vaccine; 2009 Nov; 27 Suppl 5():F67-74. PubMed ID: 19931723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulating vaccines: can health-economics tools be used profitably?
    Dhanasiri SK; Puliyel JM
    Indian Pediatr; 2007 Jan; 44(1):11-4. PubMed ID: 17277425
    [No Abstract]   [Full Text] [Related]  

  • 14. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
    Armstrong GL; Billah K; Rein DB; Hicks KA; Wirth KE; Bell BP
    Pediatrics; 2007 Jan; 119(1):e22-9. PubMed ID: 17200247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of health economic evaluations of vaccines in Brazil.
    Sartori AMC; Rozman LM; Decimoni TC; Leandro R; Novaes HMD; de Soárez PC
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-12. PubMed ID: 28129026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia.
    Touch S; Suraratdecha C; Samnang C; Heng S; Gazley L; Huch C; Sovann L; Chhay CS; Soeung SC
    Vaccine; 2010 Jun; 28(29):4593-9. PubMed ID: 20470803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model for estimating the impact of changes in children's vaccines.
    Simpson KN; Biddle AK; Rabinovich NR
    Am J Public Health; 1995 Dec; 85(12):1666-72. PubMed ID: 7503342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New vaccines--new dilemmas.
    Passwell JH; Spirer Z
    Isr Med Assoc J; 2005 Jun; 7(6):397-9. PubMed ID: 15984386
    [No Abstract]   [Full Text] [Related]  

  • 19. A learning experience from price negotiations for vaccines.
    Teerawattananon Y; Tritasavit N
    Vaccine; 2015 May; 33 Suppl 1():A11-2. PubMed ID: 25919150
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.
    De la Hoz F; Alvis N; Narváez J; Cediel N; Gamboa O; Velandia M
    Vaccine; 2010 May; 28(22):3856-64. PubMed ID: 20347057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.